Supply Chain
New research from Advisory Board, conducted in partnership with Staples Business, reveals how 102 health system supply chain and executive…
The FDA placed a clinical hold on Advaxis' combination cancer drug study March 9 after a patient death occurred last month.
Hartford (Conn.) HealthCare, formed through a series of mergers and acquisitions, unites a diverse group of healthcare providers.
Staff
In a recent interview, Joe Swartz, the administrative director of business transformation for Franciscan St. Francis Health, spoke about his organization’s ten years of effort in engaging every staff member in “kaizen,” or continuous improvement.
Mark Graban
Biogen shared plans Monday to buy Pfizer's experimental neurology drug in a deal worth up to $590 million, reports Reuters.
Here are the four latest drugs or medical devices approved by the FDA this week.
The FDA on March 6 expanded approval for a smaller size of a heart valve to treat newborns with heart defects.
TaiMed Biologics earned FDA approval for its new HIV drug Trogarzo March 6.
Over the past 18 months, Amazon has hired more than 20 employees, including software engineers, data analysts and business strategists with years of experience in healthcare or pharmaceutical industries at companies like CVS Health, Express Scripts and UnitedHealth Group, according…
The FDA on March 6 approved Oxford Immunotec's detection tests to screen for a parasite in samples of donated blood.
The shift to value-based healthcare is transforming business relationships across the care continuum. One evolving phenomenon: risk-sharing agreements between providers and healthcare suppliers, including pharmaceutical, medical device and equipment manufacturers.